Grupo de Investigación en Cáncer de Mama
NEONCOBREAST
University Hospital Aachen
Aachen, AlemaniaPublicaciones en colaboración con investigadores/as de University Hospital Aachen (4)
2022
-
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
Annals of Oncology, Vol. 33, Núm. 12, pp. 1250-1268
2021
2020
2015
-
Breast MRI: EUSOBI recommendations for women’s information
European Radiology, Vol. 25, Núm. 12, pp. 3669-3678